Single-Cell Atlas Reveals How Aging Reshapes the Thymus and T Cell Immunity
A massive single-cell study of 387,762 cells uncovers how thymic aging disrupts T cell development and reshapes peripheral immune function.
Summary
Researchers used single-cell sequencing to map 387,762 cells from the thymus and blood of young and aged humans, revealing how thymic involution undermines immune defense. Aging reduced the thymus's ability to produce T cells while boosting innate lymphocyte output. Aged thymic tissue showed inflammatory T cell profiles, loss of epithelial cells, and reduced tissue-restricted antigen expression. In peripheral blood, aging left distinct transcriptional fingerprints on T cells. The team built a naive T cell-based model to predict immune age and identified CD38 as a marker for recently exported thymic T cells. TCR repertoire diversity declined in memory and effector T cells, while virus-specific clones expanded with age.
Detailed Summary
As people age, the thymus — the organ responsible for producing mature T cells — gradually shrinks and loses function, a process called thymic involution. This leaves older adults more vulnerable to infections, cancers, and immune dysfunction. Despite its importance, the cellular and molecular mechanisms driving this decline, and its downstream effects on circulating T cells, have remained poorly understood.
In this study, researchers performed single-cell RNA sequencing and T cell receptor (TCR) repertoire sequencing on 387,762 cells collected from the thymus and peripheral blood of young and aged human donors. This large-scale, high-resolution approach allowed them to map the full landscape of T cell development and aging across both compartments simultaneously.
Within the thymus, aging was associated with a reduced capacity of early thymic progenitors to commit to the T cell lineage, while their potential to become innate lymphocytes increased. Mature T cells in aged thymuses displayed low expression of SOX4 — a transcription factor critical for T cell development — alongside inflammatory gene signatures. Thymic epithelial cells, which support T cell maturation, were depleted, and expression of tissue-restricted antigens was reduced, potentially impairing central immune tolerance.
In peripheral blood, the team identified transcriptional hallmarks of T cell aging and developed a predictive model of immune age based on naive T cell gene expression profiles. They also identified CD38 as a reliable surface marker for recent thymic emigrants — newly exported T cells — providing a practical tool for future immune monitoring. TCR diversity narrowed in memory and effector T cell compartments with age, while clonally expanded virus-specific T cells accumulated.
These findings provide a comprehensive molecular framework for understanding thymic and peripheral T cell aging in humans. Identified targets such as SOX4, thymic epithelial cell populations, and CD38 could inform therapeutic strategies aimed at restoring immune competence in older adults, though the cross-sectional nature of the study warrants cautious interpretation.
Key Findings
- Aging reduces T-lineage potential in early thymic progenitors while increasing innate lymphocyte potential.
- Aged thymic T cells show low SOX4 expression and inflammatory gene profiles alongside depleted epithelial cells.
- CD38 identified as a novel surface marker for recent thymic emigrants in peripheral blood.
- Naive T cell transcriptional profiles enabled construction of an immune age prediction model.
- TCR repertoire diversity narrows with age in memory/effector T cells; virus-specific clones expand.
Methodology
Single-cell RNA sequencing and TCR repertoire sequencing were performed on 387,762 cells from human thymus and peripheral blood of young and aged donors. Comparative transcriptomic analysis identified lineage-specific aging signatures, and machine learning was applied to naive T cell profiles to build an immune age prediction model.
Study Limitations
The study relies on cross-sectional sampling, limiting causal conclusions about the trajectory of thymic aging over time. Access to only an abstract restricts full assessment of cohort size, donor demographics, and technical validation details. Functional validation of identified markers such as CD38 in prospective clinical studies has yet to be reported.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.